Indeed, it has been demonstrated that ROR1 has an important therapeutic role in such a neoplastic disease because glucocorticoids anti-inflammatory agents (generally administred as adjuvant to chemotherapy) may induce chemoresistance by promoting ROR1-mediated stemness [32]. This evidence concerns the gene ROR1 and neoplasm.